HMGB1 and Sepsis: In murine models of lethal sepsis, administration of neutralizing HMGB1 antibodies, initiated at 24 hours after infection, improved the survival rate of mice, while decreasing the production of HMGB1 induced pro-inflammatory cytokines22,23.